<DOC>
	<DOCNO>NCT00513903</DOCNO>
	<brief_summary>This study test whether enhanced continuity pharmacy care include increase communication inpatient outpatient setting improve appropriateness medication therapy reduce number serious adverse drug event , hospitalization unscheduled office visit vulnerable patient cardiovascular disease , pulmonary disease diabetes .</brief_summary>
	<brief_title>Expanding Role Pharmacists Treating Persons With Cardiovascular Lung Diseases</brief_title>
	<detailed_description>Drugs use treat cardiovascular lung disease frequent cause hospitalization emergency department visit relate inadequate therapy ADEs . ADEs occur 25 % patient able walk may cause 17 % hospital admission among elderly . A lack communication coordination hospital set patient 's community setting , upon patient discharge , may contribute high number ADEs . By expand role pharmacist encourage communication hospital pharmacist , number ADEs may reduce . There small study examine way patient information transfer hospital community pharmacist , study involve patient ' primary care physician fully evaluate effect communication hospital community pharmacist . The purpose study evaluate effectiveness provide pharmacist case manager hospitalize patient cardiovascular lung disease reduce number ADEs , re-hospitalizations , unscheduled medical visit . This study enroll individual certain condition disease admit hospital . Participants randomly assign either control group , minimal treatment group , enhance treatment group . Participants minimal enhance treatment group meet pharmacist case manager hospital conduct medication history review . The case manager also meet participant time hospital discharge provide discharge summary educational material . Additionally , participant enhance treatment group , case manager follow : transfer discharge summary data participant 's community physician pharmacist ; call participant 3 5 day follow discharge hospital need thereafter resolve medication problem ; communicate make recommendation participant 's community physician pharmacist . All participant meet study research nurse immediately study entry complete questionnaire . Study nurse also call participant 30 90 day follow hospital discharge collect adverse event information . Surveys complete participant 's pharmacist primary care physician 90 day follow participant 's discharge hospital .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Speaks either English Spanish Willing obtain longterm prescription one community pharmacy 90day study period Diagnosed least one follow condition : high blood pressure , hyperlipidemia , heart failure , coronary artery disease , heart attack , stroke , transient ischemic attack , asthma , chronic obstructive pulmonary disease ( COPD ) , diabetes , receive oral anticoagulation therapy Admitted general medicine , family medicine , cardiology , orthopedics service hospital department Does work telephone Has hearing impairment allow use telephone Enrolled Iowa Care ( i.e. , individual community physician community pharmacist follow hospital discharge ) Life expectancy estimate less 6 month time study entry Dementia cognitive impairment Severe psychiatric psychosocial factor , include substance abuse , may impair desire ability complete aspect study Admission psychiatric , surgery , hematology/oncology service hospital department</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Pulmonary Diseases</keyword>
	<keyword>Continuity Pharmacy Care</keyword>
</DOC>